Using real-world safety data in regulatory approval decisions: Sotagliflozin and the risk of diabetic ketoacidosis.

Persons

Aaron Seth Kesselheim

Venue / Journal

Pharmacoepidemiol Drug Saf

Date

Thu, 10/01/2020 - 12:00

Additional Journal Information

29(10):1322-1324

Authors

Fralick M, Kesselheim AS.

Pubmed URL

http://www.ncbi.nlm.nih.gov/pubmed/32189390